Junyu Huo

699 total citations
47 papers, 476 citations indexed

About

Junyu Huo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junyu Huo has authored 47 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junyu Huo's work include Ferroptosis and cancer prognosis (17 papers), Cardiovascular Function and Risk Factors (7 papers) and Cancer, Lipids, and Metabolism (7 papers). Junyu Huo is often cited by papers focused on Ferroptosis and cancer prognosis (17 papers), Cardiovascular Function and Risk Factors (7 papers) and Cancer, Lipids, and Metabolism (7 papers). Junyu Huo collaborates with scholars based in China and United States. Junyu Huo's co-authors include Liqun Wu, Yunjin Zang, Qijun Shan, Jie Geng, Zhixin Jiang, Ge Guan, Qing Chang, Xinyi Fan, Peng Sun and Huan Liu and has published in prestigious journals such as Cancer Research, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Junyu Huo

44 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyu Huo China 14 233 208 161 96 87 47 476
Marjorie Barrier Canada 9 178 0.8× 245 1.2× 88 0.5× 97 1.0× 40 0.5× 13 422
Marina Fridlib United States 4 294 1.3× 214 1.0× 309 1.9× 48 0.5× 59 0.7× 6 550
Juan Yu China 13 170 0.7× 150 0.7× 99 0.6× 66 0.7× 215 2.5× 29 515
Jesús Méndez‐González Spain 9 361 1.5× 117 0.6× 194 1.2× 38 0.4× 94 1.1× 11 601
Liam A. Hurst United Kingdom 6 251 1.1× 154 0.7× 56 0.3× 86 0.9× 22 0.3× 6 521
Cheng Tang China 15 196 0.8× 158 0.8× 117 0.7× 19 0.2× 164 1.9× 40 516
Shen‐Nien Wang Taiwan 14 154 0.7× 102 0.5× 124 0.8× 39 0.4× 97 1.1× 24 458
Mario Boehm Germany 11 180 0.8× 311 1.5× 39 0.2× 215 2.2× 42 0.5× 19 496
Hai Li China 9 130 0.6× 110 0.5× 56 0.3× 54 0.6× 121 1.4× 19 356
Silin Lv China 11 209 0.9× 76 0.4× 54 0.3× 61 0.6× 69 0.8× 20 404

Countries citing papers authored by Junyu Huo

Since Specialization
Citations

This map shows the geographic impact of Junyu Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu Huo more than expected).

Fields of papers citing papers by Junyu Huo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu Huo. The network helps show where Junyu Huo may publish in the future.

Co-authorship network of co-authors of Junyu Huo

This figure shows the co-authorship network connecting the top 25 collaborators of Junyu Huo. A scholar is included among the top collaborators of Junyu Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyu Huo. Junyu Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xinyi, Xin Yi, Junyu Huo, et al.. (2025). Biomimetic patch with gradient-induced regeneration for tendon-bone interface to repair rotator cuff injury. Chemical Engineering Journal. 506. 159985–159985.
2.
3.
Zhou, Min, et al.. (2025). Screening of biomarkers for diagnosing chronic kidney disease and heart failure with preserved ejection fraction through bioinformatics analysis. Biochemistry and Biophysics Reports. 41. 101911–101911. 2 indexed citations
4.
5.
Huo, Junyu, et al.. (2023). Empagliflozin ameliorates cardiac dysfunction in heart failure mice via regulating mitochondrial dynamics. European Journal of Pharmacology. 942. 175531–175531. 21 indexed citations
6.
Zhu, Qingwei, Wei Rao, Junyu Huo, et al.. (2023). Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center. BMC Gastroenterology. 23(1). 28–28. 2 indexed citations
7.
8.
Huo, Junyu, et al.. (2022). A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma. Frontiers in Genetics. 13. 771819–771819. 9 indexed citations
9.
Huo, Junyu, Jing Guan, & Yankun Li. (2022). Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer. BMC Gastroenterology. 22(1). 364–364. 3 indexed citations
10.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability. Epigenomics. 13(11). 875–890. 19 indexed citations
11.
12.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. Journal of Immunology Research. 2021. 1–24. 11 indexed citations
13.
14.
15.
16.
Huo, Junyu, et al.. (2021). Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression. Laboratory Investigation. 102(4). 341–351. 9 indexed citations
17.
Yang, Xin, Ge Guan, Junyu Huo, et al.. (2021). TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy. Pharmacogenomics and Personalized Medicine. Volume 14. 269–278. 11 indexed citations
18.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma. Frontiers in Oncology. 11. 618976–618976. 12 indexed citations
19.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 10 indexed citations
20.
Yang, Huibin, Junyu Huo, & Xin Li. (2021). Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma. World Journal of Surgical Oncology. 19(1). 90–90. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjorie Barrier Breakdown of academic impact, for papers by Marina Fridlib Breakdown of academic impact, for papers by Juan Yu Breakdown of academic impact, for papers by Jesús Méndez‐González Breakdown of academic impact, for papers by Liam A. Hurst Breakdown of academic impact, for papers by Cheng Tang Breakdown of academic impact, for papers by Shen‐Nien Wang Breakdown of academic impact, for papers by Mario Boehm Breakdown of academic impact, for papers by Hai Li Breakdown of academic impact, for papers by Silin Lv
Rankless by CCL
2026